Author:
Niu Yimin,Li Feng,Inada Chikako,Tanaka Ken,Watanabe Shiro,Fujiwara Hironori,Sasaki-Hamada Sachie,Oka Jun-Ichiro,Matsumoto Kinzo
Funder
University of Toyama
Ministry of Education, Culture, Sports, Science and Technology, Japan
Otsuka Toshimi Scholarship Foundation
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference29 articles.
1. Kampo formulations, chotosan, and yokukansan, for dementia therapy: existing clinical and preclinical evidence;Matsumoto;J. Pharmacol. Sci.,2013
2. Chotosan, a Kampo formula, ameliorates chronic cerebral hypoperfusion-induced deficits in object recognition;Zhao;J. Pharmacol. Sci.,2007
3. Diabetes-induced central cholinergic neuronal loss and cognitive deficit are attenuated by tacrine and a Chinese herbal prescription, kangen-karyu: elucidation in type 2 diabetes db/db mice;Zhao;J. Pharmacol. Sci.,2011
4. Chotosan ameliorates cognitive and emotional deficits in an animal model of type 2 diabetes: possible involvement of cholinergic and VEGF/PDGF mechanisms in the brain;Zhao;BMC Complement. Altern. Med.,2012
5. Chotosan, a Kampo formula, ameliorates hippocampal LTD and cognitive deficits in juvenile-onset diabetes rats;Sasaki-Hamada;J. Pharmacol. Sci.,2014
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献